Phase II Trial of M7824 in Subjects With HPV Positive Malignancies

Conditions:   Human Papilloma Virus;   Cervical Cancer;   Oropharyngeal Cancer;   Anal Cancer;   Vaginal or Penile Cancer
Intervention:   Drug: M7824
Sponsor:   National Cancer Institute (NCI)
Not yet recruiting

http://ift.tt/2nOnyL4